SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (294)1/7/2003 8:31:06 PM
From: tuck  Read Replies (1) of 897
 
Hi, Erik,

I wasn't saying Elan's entire Alzheimer's immunotherapy program was dead in the water, just AGEN's chunk of it. Neither of those two back-up vaccines involve QS-21 or other AGEN products, right? Or do they? Or do we just not know until Elan says yea or nay? AGEN might get milestones on QS-21 use. It has retained manufacturing rights, that I know.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News